Clinical trial
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy…
NCT00378313 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00378313 |
|---|---|
| Title | A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer |
| Official title | A Phase 2 Study of Neoadjuvant Chemotherapy With Gemcitabine, Epirubicin and Paclitaxel (Taxol)[GET] in Locally Advanced Breast Cancer |
| Lead sponsor | NSABP Foundation Inc, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer, Breast Cancer, Locally Advanced |
| Intervention type | Drug |
| Interventions | gemcitabine, epirubicin, paclitaxel |
| Enrollment | 76 |
| Start date | Nov 1, 2001 |
| Completion | Nov 1, 2005 |
| First posted | Sep 19, 2006 |
| Last update posted | Nov 26, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: